Skip to content

Tag: Pharmacy benefit managers

Explore our medication guides and pharmacology articles within this category.

Decoding the Pharmacy: How does GoodRx sell drugs so cheaply?

5 min read
A staggering percentage of Americans forgo filling their prescriptions due to cost. The rise of services like GoodRx, which offer significant discounts, has led many to ask: How does GoodRx sell drugs so cheaply? The answer lies in navigating the opaque, multi-billion-dollar world of Pharmacy Benefit Managers (PBMs).

Answering the Big Question: Why is Wegovy so expensive in the United States?

4 min read
In the United States, the list price for a monthly supply of Wegovy is approximately $1,349, a stark contrast to prices in other developed nations like the United Kingdom, where it can cost as little as $92 [1.2.1, 1.3.1]. So, why is Wegovy so expensive in the United States? The answer lies in a uniquely complex web of factors.

The Big Question for 2025: Is Humira Being Phased Out?

4 min read
Since the first U.S. biosimilar launch in January 2023, Humira's market has been completely reshaped [1.2.3, 1.6.4]. The introduction of over a dozen competing products is driving a major shift in treatment, so is Humira being phased out? While not discontinued, its dominance is rapidly declining.

What's the catch in using GoodRx for prescription savings?

5 min read
GoodRx has reportedly helped Americans save billions on prescription costs since its founding in 2011, according to company statements. However, many users wonder, "What's the catch in using GoodRx?" as the promise of massive discounts often seems too good to be true, and for some, it might be due to privacy, insurance, and pricing complexities.